Status:
COMPLETED
Longitudinal Study of HAART, Social Networks, & Adherence
Lead Sponsor:
University of Washington
Collaborating Sponsors:
Mozambique Ministry of Health
United States President's Emergency Plan for AIDS Relief
Conditions:
Acquired Immunodeficiency Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Our study is a randomized controlled trial that aims to evaluate the effectiveness of modified directly observed therapy (mDOT) to (1) increase both short and long term adherence to HAART treatment, a...
Detailed Description
To test this hypothesis, we intend to randomize 350 ARV naïve patients starting HAART to either receive mDOT for the initial 6 weeks of treatment or standard adherence support. Both intervention and c...
Eligibility Criteria
Inclusion
- HIV+ persons initiating HAART
- Adults and children over the age of 18
- Reside in or around Beira Mozambique
- Willing and able to provide consent to participate
Exclusion
- Physically or mental incapable to make daily clinic visits
- Psychotic or demented
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT00272220
Start Date
October 1 2004
End Date
June 1 2006
Last Update
November 7 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beira Day Hosptial - Central Hospital
Beira, Sofala, Mozambique